Synthesis, in-vitro screening, and docking analysis of novel pyrrolidine and piperidine-substituted ethoxy chalcone as anticancer agents
- 389 Downloads
A series of novel-substituted chalcone analogs were synthesized and evaluated for antiproliferative activity against estrogen receptor-positive MCF-7 breast cancer cell lines. Among the synthesized derivatives 4a, 5a, 5b, 5c, 5e, 5′a, and 5′d show good antiproliferative activity as compared to standard tamoxifen. The study highlighted the advantage of introducing the amine side chain pharmacophore in substituted chalcone enhances the anticancer potential. The study also suggests that these analogs can serve as better therapeutic agents against breast cancer and can provide starting point for building more potent analogs in future. The binding mechanism and ADME properties of target compounds were analysed using Schrödinger software.
KeywordsChalcone Breast cancer Molecular docking ADME
The authors are thankful to Tata Memorial Centre-Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) Kharghar, Navi Mumbai for in-vitro assay against breast cancer activity. This work was supported by the Department of Science and Technology (DST), New Delhi, India (Project File No. SR/FT/LS-132/2012 & Sanction Diary No. SERB/F/4302/2012-13).
- Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2012) GLOBOCAN 2012v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11.Google Scholar
- International Agency for Research on Cancer, Lyon, France (2013). http://globocan.iarc.fr. Accessed 2 July 2014.
- Johnston SRD, Ford H, Ross P, Brighton D, Wood M (2005) The Royal Marsden Hospital hand book of cancer chemotherapy. Elsevier Churchill Livingstone, London, pp 1–17Google Scholar
- Katzenellenbogen BS (2002) Defining the “S” in SERMs. J Appl Sci 295:2380–2381Google Scholar
- Maestro, version 9.3, Schrödinger, LLC, New York, NY, 2012.Google Scholar
- Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A, Gray-Goodrich M, Campbell H, Boyd MR (1991) Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer 83:757–766CrossRefGoogle Scholar
- QikProp, version 3.5, Schrödinger, LLC, New York, NY, 2012.Google Scholar